One week after being vaccinated with AstraZeneca, a woman in Sweden lost her life. As the Medical Products Service of the country announced today (18/03), the victim was previously completely healthy.
«This is a case of blood clots in the arteries and veins and heavy bleeding, that is, the rare disorder that the European Medicines Agency (EMA) research focuses on, “said Veronica Arthurson, head of drug safety at the Swedish Medicines Agency.
According to the APE-MPE, Stockholm announced earlier today that it will extend the suspension of its use AstraZeneca vaccine until next week.
However, the European Medicines Agency subsequently announced that remains convinced of the benefits of the AstraZeneca vaccine far outweigh the potential risks, following research into reports of thromboembolic events that have prompted more than 12 countries to suspend its use.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
